Precipio Inc. (PRPO)

Name: Precipio Inc. (PRPO) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Precipio Inc. (PRPO)

Stock Card

$30.41

$-0.45 (-1.44%)

As on 26-Aug-2026 16:00EDT

Market cap

$55 Mln

Revenue (TTM)

$27 Mln

P/E Ratio

P/B Ratio

3.6

Div. Yield

0 %

Precipio (PRPO) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 29.57 High: 32.57

52 Week Range

Low: 14.24 High: 33.63

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.1 %
ROCE

-- %
Industry P/E

44.46
EV/EBITDA

79.5
Debt to Equity

0
Book Value

$--
EPS

$-0.7
Face value

--
Shares outstanding

1,790,188

10 Years Aggregate

CFO

$-77.51 Mln

EBITDA

$-74.25 Mln

Net Profit

$-142.98 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Precipio (PRPO)	32.3	28.4	27.8	114.3	61.2	-15.1	-37.0
BSE Sensex	-8.5	1.9	1.3	-5.1	6.1	6.7	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 26-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Precipio (PRPO)	314.8	-14.7	-41.1	-65.1	-23.7	1.0	-11.3
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Precipio (PRPO)	30.4	54.5	27.5	-1.2	-4.5	-8.3	--	3.6
10X Genomics Inc (TXG)	64.3	8,484.6	616.9	-75.1	1.7	-9.3	--	10.1
Avantor (AVTR)	14.5	9,638.1	6,561.1	-578.0	-4.5	-10.3	--	1.7
Bio-Rad Laboratories	365.1	9,761.6	2,589.3	222.4	-6.0	3	44.5	1.3
Bruker (BRKR)	57.1	9,074.5	3,499.6	-71.2	0.5	-3.2	--	3.8
Glaukos Corp (GKOS)	180.6	10,905.5	612.8	-188.1	-30.6	-28.1	--	16.4
Lantheus Holdings (LNTH)	100.8	6,525.3	1,556.3	275.3	24.6	22.9	24	5.0
Merit Medical Systems (MMSI)	90.5	5,420.5	1,579.2	145.6	14.3	8.9	37.2	3.2
Penumbra (PEN)	323.1	12,752.7	1,504.9	160.6	13.6	10.9	79.4	8.4
Repligen (RGEN)	180.3	10,222.2	785.1	41.5	9.9	2	251.6	4.8

Shareholding Pattern

View Details

About Precipio (PRPO)

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic... diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut. Read more

Founder, President, CEO & Director

Mr. Ilan Danieli
Founder, President, CEO & Director

Mr. Ilan Danieli
Headquarters

New Haven, CT
Website

https://www.precipiodx.com

FAQs for Precipio (PRPO)

What is the current share price of Precipio Inc (PRPO) Today?

The share price of Precipio Inc (PRPO) is $30.41 (NASDAQ) as of 26-Aug-2026 16:00 EDT. Precipio Inc (PRPO) has given a return of 61.25% in the last 3 years.

What is the current PB & PE ratio of Precipio Inc (PRPO)?

Since, TTM earnings of Precipio Inc (PRPO) is negative, P/E ratio is not available.
The P/B ratio of Precipio Inc (PRPO) is 3.59 times as on 21-Aug-2026, a 7 discount to its peers’ median range of 3.84 times.

PE & PB ratio at the end of financial year.